Global® AP™ Total Shoulder Arthroplasty
A Multi-center Clinical Study of the Global® AP™ Shoulder in Total Shoulder Arthroplasty
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85027
- The Core Institute
-
-
North Carolina
-
Asheville, North Carolina, United States, 28801
- Mission Hospitals Research Institute
-
-
Ohio
-
Cincinnati, Ohio, United States, 45230
- Wellington Orthopaedics and Sports Medicine
-
-
Utah
-
Park City, Utah, United States, 84060
- Rosenberg Cooley Metcalf Clinic
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients selected for inclusion will present for primary shoulder arthroplasty with a diagnosis of osteoarthritis and will consent to participate.
Exclusion Criteria:
- Are under 18 years of age or over 70
- Diagnosis of AVN, Inflammatory Arthritis, Fracture or Malunion.
- Have a hemi-arthroplasty
- Have destruction of the proximal humerus that precludes rigid fixation of the humeral component
- Have arthritis with insufficient cuff tissue
- Have had a failed rotator cuff surgery
- Have loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified
- Have evidence of active infection
- Present with a condition of neuromuscular compromise of the shoulder (e.g., neuropathic joints or brachial plexus injury with a flail shoulder joint) - Have a known active metastatic or neoplastic disease
- Are unwilling or unable to comply with a rehabilitation program or would fail to return for the postoperative follow-up visits prescribed by the protocol
- Are skeletally immature.
- Have a known allergic reaction to implant metals, polyethylene or a tissue reaction to corrosion or wear products
- Have other conditions such as central nervous system disturbances, alcohol or drug addiction, etc. that may make effective evaluation of the joint replacement difficult or impossible
- Are currently participating in another clinical study
- Are taking > 10mg/day corticosteroids (e.g. prednisone) excluding inhalers, within 3 months prior to surgery
- Are currently involved in any personal injury litigation, medical legal or worker's compensation claims.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Global® AP™ Shoulder
|
Total shoulder arthroplasty
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Constant Shoulder Score
Time Frame: Pre-op, 6, 12, 24 months
|
Pre-op, 6, 12, 24 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
SF-12
Time Frame: Pre-op, 6,12, 24 months
|
Pre-op, 6,12, 24 months
|
|
Penn/ASES
Time Frame: Pre-Op, 6, 12, and 24 months
|
Pre-Op, 6, 12, and 24 months
|
|
Radiographic Data
Time Frame: Pre-Op, 6 weeks, 6, 12, and 24 months
|
Pre-Op, 6 weeks, 6, 12, and 24 months
|
|
Quality of Life Survey
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Sam Himden, BA, DePuy Orthopaedics
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 05071
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.